These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 28279752)

  • 21. Thyroid function in breast-fed infants is not affected by methimazole-induced maternal hypothyroidism: results of a retrospective study.
    Azizi F
    J Endocrinol Invest; 2003 Apr; 26(4):301-4. PubMed ID: 12841536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicities associated with 1-month treatment with propylthiouracil (PTU) and methimazole (MMI) in male rats.
    Nambiar PR; Palanisamy GS; Okerberg C; Wolford A; Walters K; Buckbinder L; Reagan WJ
    Toxicol Pathol; 2014 Aug; 42(6):970-83. PubMed ID: 24067673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
    Toderian AB; Lawson ML
    Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of developmental hypothyroidism induced by maternal administration of methimazole or propylthiouracil on the immune system of rats.
    Nakamura R; Teshima R; Hachisuka A; Sato Y; Takagi K; Nakamura R; Woo GH; Shibutani M; Sawada J
    Int Immunopharmacol; 2007 Dec; 7(13):1630-8. PubMed ID: 17996672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
    Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
    J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal transfer of methimazole and effects on thyroid hormone availability in embryonic tissues.
    Van Herck SL; Geysens S; Bald E; Chwatko G; Delezie E; Dianati E; Ahmed RG; Darras VM
    J Endocrinol; 2013 Jul; 218(1):105-15. PubMed ID: 23608220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
    Reinwein D; Benker G; Lazarus JH; Alexander WD
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1516-21. PubMed ID: 8501160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repressed activity of peritoneal macrophages in methimazole-induced hypothyroid mice.
    Liu WK; Tsui KW; Wong CC
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(2):131-6. PubMed ID: 8094923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental exposure to methimazole increases anxiety behavior in zebrafish.
    Reider M; Connaughton VP
    Behav Neurosci; 2015 Oct; 129(5):634-42. PubMed ID: 26214210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
    Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
    Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency.
    Dhanalakshmi C; Janakiraman U; Moutal A; Fukunaga K; Khanna R; Nelson MA
    Neurobiol Dis; 2021 Feb; 149():105224. PubMed ID: 33359140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hyperthyroidism with a small single daily dose of methimazole.
    Shiroozu A; Okamura K; Ikenoue H; Sato K; Nakashima T; Yoshinari M; Fujishima M; Yoshizumi T
    J Clin Endocrinol Metab; 1986 Jul; 63(1):125-8. PubMed ID: 3011835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels.
    Fukunaga K; Izumi H; Yabuki Y; Shinoda Y; Shioda N; Han F
    J Pharmacol Sci; 2019 Feb; 139(2):51-58. PubMed ID: 30600144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sister-chromatid exchanges in lymphocytes from methimazole-induced hypothyroid mice.
    Liu WK; Tsui KW; Lai KW; Xie Y
    Mutat Res; 1995 Feb; 326(2):193-7. PubMed ID: 7529884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothyroidism Enhanced Ectonucleotidases and Acetylcholinesterase Activities in Rat Synaptosomes can be Prevented by the Naturally Occurring Polyphenol Quercetin.
    Baldissarelli J; Santi A; Schmatz R; Abdalla FH; Cardoso AM; Martins CC; Dias GR; Calgaroto NS; Pelinson LP; Reichert KP; Loro VL; Morsch VM; Schetinger MR
    Cell Mol Neurobiol; 2017 Jan; 37(1):53-63. PubMed ID: 26879755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of selenium on hypothyroidism induced by methimazole (MMI) in lactating rats and their pups.
    Amara IB; Bouaziz H; Guermazi F; Zeghal N
    Acta Biol Hung; 2010 Jun; 61(2):145-57. PubMed ID: 20519169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
    Werner RS; Romaldini JH; Farah CS; Werner MC; Bromberg N
    Thyroid; 1991; 1(4):293-9. PubMed ID: 1688155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101) treatment rescues olfactory bulbectomy-induced memory impairment by activating Ca2+/calmodulin kinase II and protein kinase C in mouse hippocampus.
    Han F; Shioda N; Moriguchi S; Yamamoto Y; Raie AY; Yamaguchi Y; Hino M; Fukunaga K
    J Pharmacol Exp Ther; 2008 Jul; 326(1):127-34. PubMed ID: 18388258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
    Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
    Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antioxidants (vitamin C, E and turmeric extract) on methimazole induced hypothyroidism in rats.
    Deshpande UR; Joseph LJ; Patwardhan UN; Samuel AM
    Indian J Exp Biol; 2002 Jun; 40(6):735-8. PubMed ID: 12587721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.